Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(27 sites)
United States
Rocky Mountain Cancer Center, Colorado Springs, Colorado South Florida Oncology and Hematology, Plantation, Florida Illinois Cancer Specialists, Arlington Heights, Illinois Comprehensive Urologic Care, Lake Barrington, Illinois First Urology, Jeffersonville, Indiana